← Eichor
Condition: Gastric Cancer Gc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gastric Cancer Gc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
NA · 1 location(s) · National Cancer Center, Korea · NCT04890171Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC
Phase 3 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT04342910A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gast
Phase 2 · 70 location(s) · AstraZeneca · NCT07069712Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
Phase 1/Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06572319BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer
Phase 1 · 1 location(s) · Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. · NCT06773312A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With H
Phase 1 · 2 location(s) · Shenzhen Xinhe Biomedical · NCT07594964[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 2 · 6 location(s) · Blue Earth Diagnostics · NCT07702292Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Phase N/A · 5 location(s) · University of Latvia · NCT04022109A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Bristol-Myers Squibb · NCT06730750Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscor
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06157996Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esopha
Phase N/A · 1 location(s) · P. Herzen Moscow Oncology Research Institute · NCT07441785Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06341595Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Phase 1/Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06650332Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07243015Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase 3 · 15 location(s) · SOFIE · NCT07217704The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer
Phase N/A · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07183150Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junctio
Phase 2 · 1 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT07165847THE-0504 in Patients With Solid Tumors
Phase 1 · 1 location(s) · Thena Biotech S.r.l. · NCT07646106Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Phase 2 · 1 location(s) · Peking University · NCT06023758Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
NA · 1 location(s) · Qilu Hospital of Shandong University · NCT07635836A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC)
Phase 2 · 1 location(s) · Shanghai Changzheng Hospital · NCT04278222Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric
Phase 2 · 1 location(s) · Beijing Friendship Hospital · NCT07315854A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT06882746Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Phase 3 · 5 location(s) · Ruijin Hospital · NCT07366528Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07474324A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Phase 1 · 10 location(s) · Epkin · NCT06789172Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)
Phase N/A · 9 location(s) · Qun Zhao · NCT07401199XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
Phase 1/Phase 2 · 2 location(s) · West China Hospital · NCT06742411
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.